AstraZeneca has a P/B Ratio of 5.84. The consensus among Wall Street research analysts is that investors should "hold" AstraZeneca stock. AstraZeneca PLC (AZN:LSE) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Want to see which stocks are moving? ASTRAZENECA PLC AZN Company page - Search stock, chart, recent trades, company information, trading information, company news, fundamentals One share of AZN stock can currently be purchased for approximately GBX 6,951. Learn everything you need to know about successful options trading with this three-part video course. The biopharmaceutical company can be reached via phone at +44-20-73045000. AstraZeneca trades on the London Stock Exchange (LON) under the ticker symbol "AZN.". Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. AstraZeneca does not have a long track record of dividend growth. Liberum says it likes AstraZeneca’s pipeline of drugs into the oncology space which should allow it to expand its overall product sales and boost revenues. View analyst ratings for AstraZeneca or view top-rated stocks. The company's average rating score is 2.45, and is based on 14 buy ratings, 1 hold rating, and 5 sell ratings. Their forecasts range from GBX 6,690 to £100. All information is provided free of charge, 'as-is', and you use it at your own risk. The AstraZeneca share price is at a historical high. AstraZeneca PLC (AZN:LSE) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. With a AstraZeneca share price of 8,293p, the current yield is 2.8% and more than respectable given the recent dividend cuts to FTSE 100 companies. AstraZeneca has received 52.11% “underperform” votes from our community. Over the past six months, the AstraZeneca share price (LON: AZN) (AZN.L) has declined by over 15%. Add a 20% takeover premium to that number and you've got the £58.85 figure at which AstraZeneca … You can opt out at any time. Watch the video here. AstraZeneca PLC () Stock Market info Recommendations: Buy or sell AstraZeneca stock? Receive a free world-class investing education from MarketBeat. AstraZeneca's mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. AstraZeneca's share price was however down 2.28 percent in mid-afternoon trading in London. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. 20 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last twelve months. AstraZeneca has a P/B Ratio of 5.89. The AstraZeneca share price (LON: AZN) (AZN.L) has a forward price-earnings ratio of 24.5 using this year’s forecast earnings per share figure. With our newsletters and social media channels. AstraZeneca pays an annual dividend of GBX 207 per share and currently has a dividend yield of 2.98%. British Honey Company CEO Michael Williams gives an operational update to London South East. Shares provides unbiased commentary, ideas, views and news on stocks, funds, pensions and savings. London South East does not authorise or approve this content, and reserves the right to remove items at its discretion. Identify stocks that meet your criteria using seven unique stock screeners. Learn about financial terms, types of investments, trading strategies and more. View all of AZN's competitors. You may vote once every thirty days. AstraZeneca plc. AstraZeneca's management team includes the following people: Exec. AstraZeneca has received a consensus rating of Hold. Date Broker name New Price Old price target New price target Broker change; 08-Mar-21: Deutsche Buy: 7,005.00p: 0.00p: 10,000.00p: Reiteration: 24-Feb-21: Deutsche Buy According to analysts' consensus price target of GBX 8,639.41, AstraZeneca has a forecasted upside of 24.3% from its current price of GBX 6,951. Investors of record on Thursday, February 25th will be paid a dividend of GBX 137.40 per share on Monday, March 29th. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. The ex-dividend date of this dividend is Thursday, February 25th. It also offers other medicines and COVID-19 products, including Synagis, Fluenz Tetra/FluMist Quadrivalent, Seroquel IR/Seroquel XR, Vimovo, Movantik/Moventig, Nexium, Losec/Prilosec, and COVID-19 Vaccine AstraZeneca. In other words, AstraZeneca shares trade at around 30x recent earnings. Looking for new stock ideas? In the past three months, AstraZeneca insiders have bought more of their company's stock than they have sold. AstraZeneca employs 76,100 workers across the globe. AstraZeneca plc. A closer look at the one-day chart shows relatively steady price action since May. The official website for AstraZeneca is www.astrazeneca.com. Sign-up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. © American Consumer News, LLC dba MarketBeat® 2010-2021. Semtexsam MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Don't have an account? While London South East do their best to maintain the high quality of the information displayed on this site, we cannot be held responsible for any loss due to incorrect information found here. The P/E ratio of AstraZeneca is 28.78, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 39.60. Volume 1,959,667.00: The lowest and the highest price a share has reached in the trading day. AstraZeneca vaccine may reduce spread by 67% — and protection remains over 3-month dosage gap Feb. 3, 2021 at 3:35 p.m. Since then, AZN stock has decreased by 0.1% and is now trading at GBX 6,951. Click here to register. ), AstraZeneca has received 1,803 “underperform” votes. Wallet Investor then forecasts the share price to rise to £112.56 by December 2022, £128.44 by December 2023 and up to £159.18 by November 2025. The company's marketed products include Tagrisso, Lynparza, Imfinzi, Enhertu, Koselugo, Lumoxiti, Equidacent, Zoladex, Faslodex, Iressa, Arimidex, Casodex/Cosudex, and others for oncology diseases; Onglyza, Bydureon, Lokelma, Byetta, Qtern, Symlin, and others for cardiovascular, renal, and metabolism diseases; and Symbicort, Pulmicort, Fasenra, Daliresp/Daxas, Duaklir, Tudorza/Eklira, Bevespi, Breztri, Anifrolumab, and others for respiratory and immunology diseases. AstraZeneca Price Target, Predictions & Analyst Ratings Searched 575 Times GBX 6,985.63-25.37 (-0.36 %) (As of 03/12/2021 01:03 PM ET) ... Average Share Price and Price Target by Month. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Please log in to your account or sign up in order to add this asset to your watchlist. All rights reserved. View which stocks are hot on social media with MarketBeat's trending stocks report. Based on aggregate information from My MarketBeat watchlists, some companies that other AstraZeneca investors own include GlaxoSmithKline (GSK), NVIDIA (NVDA), Gilead Sciences (GILD), Intel (INTC), Vodafone Group (VOD), Advanced Micro Devices (AMD), Alibaba Group (BABA), Pfizer (PFE), QUALCOMM (QCOM) and The Hain Celestial Group (HAIN). To see all exchange delays and terms of use please see disclaimer. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AZN, but not buy additional shares or sell existing shares. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. (Add your “underperform” vote.). On average, Wall Street analysts predict that . Free registration. Vice-Pres of BioPharmaceuticals R&D, Exec. AstraZeneca said in a statement that its vaccine … FTSE 100,FTSE 350,FTSE 350 Low Yield,FTSE 350 (ex IT),FTSE All-Share,FTSE All-Share (ex IT),FTSE Eurotop 100 Index,FTSEurofirst 300,FTSE techMARK All-Share Instrument market cap 94,410.79 Learn more. (Add your “outperform” vote. That said, any plausible AstraZeneca share price prediction should take into account that this lower trend line has held firm and should serve as support unless a significantly negative development hits the company. RE: AstraZeneca : Barclays raises target price to 10000p from 9000p Tue 14:31 AstraZeneca: Deutsche Bank reiterates buy with a target price of 10,000p. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. ASTRAZENECA PLC AZN Company page - Search stock, chart, recent trades, company information, trading information, company news, fundamentals With a AstraZeneca share price of 8,293p, the current yield is 2.8% and more than respectable given the recent dividend cuts to FTSE 100 companies. To some investors, that may sound excessive while many of the pharma stock’s FTSE 100 index (INDEXFTSE: UKX) peers have valuations that are much, much lower. Great investment tools with live data. AstraZeneca has received 1,657 “outperform” votes. Astrazeneca shares fell after it warned that the coronavirus epidemic will hit the business for 'up to a few months'.. The average Astrazeneca stock price prediction forecasts a potential downside of N/A from the current AZN share price of $49.81. The AstraZeneca (LSE: AZN) share price has delivered substantial rewards over the past 12 months. Get daily stock ideas top-performing Wall Street analysts. Volume 1,959,667.00: The lowest and the highest price a share has reached in the trading day. Share Price Information for Astrazeneca (AZN) Share Price is delayed by 15 minutes . monthly and annualsubscriptions available. This is an increase from AstraZeneca's previous dividend of GBX 69.60. On average, they anticipate AstraZeneca's share price to reach GBX 8,639.41 in the next twelve months. View AstraZeneca's dividend history. Sharecast: share prices, live trading charts, international company research and market news alerts for investors and financial media. Share Price: 6,933.00. - Motley Fool, After reports of blood clots, some countries pause use of AstraZeneca Covid vaccine - NBC News, What Else Can Go Wrong With AstraZeneca’s Covid-19 Vaccine? AstraZeneca plc. The AZN share price is £84.45 and current earnings per share … AstraZeneca vaccine may reduce spread by 67% — and protection remains over 3-month dosage gap Feb. 3, 2021 at 3:35 p.m. The dark blue line represents the company's actual price. AstraZeneca's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 30x. The dividend payout ratio of AstraZeneca is 84.98%. MarketBeat's community ratings are surveys of what our community members think about AstraZeneca and other stocks. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium. The P/E ratio of AstraZeneca is 28.53, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 39.80. Vote “Underperform” if you believe AZN will underperform the S&P 500 over the long term. Astrazeneca plc - ADR Stock Forecast, AZN stock price prediction. Vaccine Production The UK-based drug company is preparing for the production and distribution of 2 billion doses of a COVID-19 vaccine that would be monumental for the fight against COVID-19. Our Accessibility Statement View AstraZeneca's dividend history. The chart below shows how a company's share price and consensus price target have changed over time. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. The P/E is the ratio of a company’s share price to the company’s current or forecast earnings per share. View recent trades and share price information for AstraZeneca plc (AZN) Ordinary US$0.25 So if the average share price forecast of 24 analysts covering the AZN stock is £94 in 12 months’ time, as per the Financial Times, then I’m optimistic. MarketBeat just released five new trading ideas, but AstraZeneca wasn't one of them. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Today's open 6,959.00p: At the end of the trading day there is an official closing price for every share. Vice-Pres of BioPharmaceuticals Bus. Vice-Pres of Operations & Information Technology, Exec. One bank, Citi, declared AstraZeneca's "intrinsic value" to be £49 a share. Payout ratios above 75% are not desirable because they may not be sustainable. AstraZeneca has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Wall Street analysts have given AstraZeneca a "Hold" rating, but there may be better short-term opportunities in the market. A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. The lowest and the highest price a share has reached in the trading day. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. AC Investment Inc. delivers machine learning based share price forecast. Fundamental company data provided by Zacks Investment Research. We interviewed Aquis-listed British Honey Company Chairman and CEO Michael Williams. The P/E ratio of AstraZeneca is 28.53, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 32.68. AZN share price forecast. The official announcement can be accessed at this link. But this pharmaceutical company is also a relatively new one – it was formed in 1999. AstraZeneca's stock was trading at GBX 6,955 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). The dividend payout ratio of AstraZeneca is 84.98%. Datafeed and UK data supplied by NBTrader and Digital Look. This suggests a possible upside of 24.3% from the stock's current price. BOSTON (AI Forecast Terminal) Wed, Nov 18, '20 AI Forecast today took the forecast actions: In the context of stock price realization of AZN ASTRAZENECA PLC is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. AstraZeneca is scheduled to release its next quarterly earnings announcement on Friday, April 30th 2021. AstraZeneca is a gigantic corporation with a market capitalization of more than £110 billion. Astrazeneca plc - ADR Stock Forecast, AZN stock price prediction. Share Price Information for Astrazeneca (AZN) Share Price is delayed by 15 minutes . Shares of AstraZeneca jumped as much as 4% in Monday trades, to $50.28. Free registration. AstraZeneca pays a meaningful dividend of 2.98%, higher than the bottom 25% of all stocks that pay dividends. AstraZeneca is headquartered at 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. Stock forecasting service Wallet Investor is bullish in its Astrazeneca share price prediction, putting the stock at an average of £82.34 in January 2021 and reaching £96.66 by December. Latest AstraZeneca PLC (AZN:LSE) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. The AstraZeneca (LSE: AZN) share price has delivered substantial rewards over the past 12 months. This suggests a possible upside of 24.8% from the stock's current price. Today's open 6,959.00p: At the end of the trading day there is an official closing price for every share. To some investors, that may sound excessive while many of the pharma stock’s FTSE 100 index (INDEXFTSE: UKX) peers have valuations that are much, much lower. Great investment tools with live data. See what's happening in the market right now with MarketBeat's real-time news feed. Unit, Sr. VP and Head of Research, Early Devel. 16 Wall Street analysts have issued 1-year price objectives for GlaxoSmithKline's stock. This represents a dividend yield of 1.87%. Shares provides unbiased commentary, ideas, views and news on stocks, funds, pensions and savings. AstraZeneca Share Price History. Some companies that are related to AstraZeneca include GlaxoSmithKline (GSK), Bayer Aktiengesellschaft (BAYN), Dechra Pharmaceuticals (DPH), Hutchison China MediTech (HCM), Vectura Group (VEC), Beximco Pharmaceuticals (BXP), ECO Animal Health Group (EAH), Allergy Therapeutics (AGY), Trilogy International Partners (TRL), Sareum Holdings plc (SAR.L) (SAR), Futura Medical (FUM), Avivagen (VIV), N4 Pharma (N4P), Cathay International Holdings Limited (CTI.L) (CTI) and Antisense Therapeutics (ANP). AstraZeneca declared a dividend on Thursday, February 11th. Manage your personalised Watchlist.Set up an online Virtual Portfolio.Participate in Share Chat.See more trades and director dealings.Play the Fantasy Share Trading Game. Shares of AZN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). View analysts' price targets for AstraZeneca or view top-rated stocks among Wall Street analysts. VP of Sustainability & Chief Compliance Officer, Exec. In that time, the FTSE 100 index (INDEXFTSE: UKX) is up 8%. Astrazeneca's share price could stay at $63.00 by Mar 2, 2022. The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates. The latest AstraZeneca plc (AZN) Ordinary US$0.25 share price (AZN). The company serves primary care and specialty care physicians through distributors and local representative offices. Price to Book Value per Share Ratio. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Before that, Astra was a Swiss drug manufacturer. & Oncology R&D, Start Your Risk-Free Trial Subscription Here, Editor of top German newspaper suspended in compliance probe, Timing key in consulting deal between FirstEnergy, regulator, You Must Recognize Your Own Achievements First Before Expecting Others To, The Latest: Paris may face new lockdown as ICUs fill up, 'Big burden' for schools trying to give kids internet access, The Latest: Pakistan imposes partial lockdown in some areas, Three Mall Retailers For Your Reopening Watchlist, 3 Growth Stocks with Above Market Dividend Yields, 3 Best Stocks to Buy That You’ve Probably Never Heard Of, Ferroglobe Will Get a Big Lift From Demand For Silcon Wafers, Blue Bird Stock is a Dual Tailwinds EV and Re-Opening Play, Nautilus Stock is a Pullback Buying Opportunity Here, The Launch of Truforma Should Send Zomedica to An All-Time High, Defi Markets Pause But New Highs Are In Sight, 7 Stocks That Cathie Wood is Buying And You Should Too, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, UPDATE 1-Ireland temporarily suspends Astrazeneca COVID-19 vaccine, AstraZeneca's lower EU vaccine supply target hinges on factory approval - Reuters, Was AstraZeneca Smart to Sell Its Moderna Shares? Wall Street Stock Market & Finance report, prediction for the future: You'll find the AstraZeneca share forecasts, stock quote and buy / sell signals below.According to present data AstraZeneca's AZNCF shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). ... Datafeed and UK data supplied by NBTrader and Digital Look. On average, they anticipate GlaxoSmithKline's share price to reach GBX 1,572.31 in the next twelve months. The AstraZeneca share price: Why I would buy and hold the stock fool.co.uk - Rupert Hargreaves | Saturday, 20th February, 2021 | More on: AZN. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. That’s a near-25% underperformance from the pharma stock. View our full suite of financial calendars and market data tables, all for free. View our earnings forecast for AstraZeneca. View which stocks have been most impacted by COVID-19. AstraZeneca PLC discovers, develops, manufactures, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infection, neuroscience, and gastroenterology worldwide. Export data to Excel for your own analysis. Learn more. 20 Wall Street analysts have issued 1 year price objectives for AstraZeneca's stock. Vote “Outperform” if you believe AZN will outperform the S&P 500 over the long term. Do Not Sell My Information. Several analysts have AstraZeneca as a buy recommendation, including Liberum, which upped its target price for the firm to £88.70 from £88.10. Specifically, they have bought £19,811.82 in company stock and sold GBX 0 in company stock. Climbing steadily over the last 10 years it dropped in March in the stock market crash before exploding 53% to today’s peak price of 9,670p. He explained the company's roots as a producer of high quality British Honey to transitioning into a maker of honey-infused British gin and other spirits. Get … It has a collaboration agreement with Daiichi Sankyo to develop and commercialize DS-1062 for the treatment of trophoblast cell-surface antigen 2 (TROP2) tumor; and AliveCor, Inc. to develop non-invasive potassium monitoring solutions. Get Live Data. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. AstraZeneca has a market capitalization of £91.25 billion and generates £26.62 billion in revenue each year. The AstraZeneca share price: Why I would buy and hold the stock fool.co.uk - Rupert Hargreaves | Saturday, 20th February, 2021 | More on: AZN. The latest AstraZeneca : Equity price detail and Prediction AstraZeneca share price prediction. The AstraZeneca share price (LON: AZN) (AZN.L) has a forward price-earnings ratio of 24.5 using this year’s forecast earnings per share figure. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Vaccine Production The UK-based drug company is preparing for the production and distribution of 2 billion doses of a COVID-19 vaccine that would be monumental for the fight against COVID-19. Interestingly, AstraZeneca shares ended up succumbing to a bearish head and shoulders pattern that I highlighted in a previous article last year, with the price dropping below the 8,050p neckline signalled back then to the low 7,000s, producing a 13 per cent upside for short-sellers at that point. Get short term trading ideas from the MarketBeat Idea Engine. - Forbes, UPDATE 1-S.Korea reports 3-week high 490 coronavirus cases, Europe's Vaccination Drive Shaky As Bloc Grapples With Safety Scare Related To AstraZeneca COVID-19 Shot: Report, AstraZeneca Vaccine Shots Delayed in Thailand Amid Blood Clot Concerns, EXCLUSIVE-AstraZeneca to seek U.S. authorization for COVID-19 vaccine this month or early next -sources, Denmark, Norway, Iceland and Bulgaria halt use of AstraZeneca’s COVID-19 vaccine over reports of blood clots, ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important March 29 Deadline - AZN, U.S. reaches 100 million COVID-19 vaccine doses, Biden pledges vaccines open to all by May, Lawsuits Filed Against Azn, Otrk and Atnx - Jakubowitz Law Pursues Shareholders Claims, Denmark and Norway Suspend AstraZeneca Covid-19 Vaccine Over Blood Clot Worries, Canada says AstraZeneca vaccine is safe after Norway and Denmark suspend use, UPDATE 1-Canada says AstraZeneca vaccine is safe after Norway and Denmark suspend use, India agrees 'significantly lower' AstraZeneca vaccine price - Reuters, UPDATE 1-Italy bans AstraZeneca batch following two deaths in Sicily -source - Yahoo Finance, Exclusive: EU told to expect no AstraZeneca vaccines from U.S. in near future - sources - Reuters, France sees no reason to suspend AstraZeneca COVID shots - minister, view top-rated stocks among Wall Street analysts, Cathay International Holdings Limited (CTI.L) (CTI), Receive Analysts' Upgrades and Downgrades Daily.